• 1. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 2. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 3. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 4. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 5. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzopyrazoles Indazoles

Introduction to 5-bromo-2-methyl-indazole-3-carbaldehyde (CAS No. 1251023-52-5)

5-bromo-2-methyl-indazole-3-carbaldehyde, identified by its Chemical Abstracts Service (CAS) number 1251023-52-5, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical and medicinal chemistry. This compound belongs to the indazole class, characterized by a fused benzene and pyrazole ring system, which is a common structural motif in biologically active molecules. The presence of a bromine substituent at the 5-position and a methyl group at the 2-position, along with an aldehyde functionality at the 3-position, imparts unique electronic and steric properties that make it a valuable scaffold for drug discovery.

The aldehyde group in 5-bromo-2-methyl-indazole-3-carbaldehyde serves as a versatile handle for further chemical modifications, enabling the synthesis of a wide array of derivatives through condensation, oxidation, or reduction reactions. This reactivity has been exploited in various synthetic pathways to develop novel compounds with potential therapeutic applications. The bromine atom, being electron-withdrawing, influences the electronic distribution within the molecule, which can be harnessed to modulate interactions with biological targets.

Recent advancements in medicinal chemistry have highlighted the importance of indazole derivatives in the development of small-molecule inhibitors and activators. Studies have demonstrated that modifications within the indazole core can significantly alter pharmacokinetic and pharmacodynamic properties, making them attractive for therapeutic intervention. The methyl group at the 2-position not only contributes to the steric environment but also plays a role in determining metabolic stability and binding affinity.

In the context of contemporary research, 5-bromo-2-methyl-indazole-3-carbaldehyde has been investigated for its potential role in modulating enzyme activity and receptor binding. For instance, derivatives of this compound have shown promise in inhibiting enzymes involved in inflammatory pathways, such as cyclooxygenase (COX) and lipoxygenase (LOX). The aldehyde functionality allows for facile coupling with nucleophiles, enabling the synthesis of peptidomimetics and other complex molecules that mimic natural bioactive peptides.

One notable area of research involves the use of 5-bromo-2-methyl-indazole-3-carbaldehyde as a precursor in the synthesis of kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling pathways, and their dysregulation is associated with various diseases, including cancer. By leveraging the reactivity of the aldehyde group and the electronic properties imparted by the bromine and methyl substituents, researchers have designed analogs that selectively inhibit specific kinases. These inhibitors have shown preclinical efficacy in models of cancer and inflammatory diseases.

The indazole scaffold itself has a rich history in drug discovery, with several approved drugs featuring this motif. For example, certain antifungal agents and antimicrobial compounds incorporate indazole derivatives into their structures. The structural flexibility of indazole allows for diverse functionalization patterns, making it an ideal platform for generating libraries of compounds for high-throughput screening.

Another emerging application of 5-bromo-2-methyl-indazole-3-carbaldehyde is in the development of photodynamic therapy (PDT) agents. PDT involves the use of photosensitizers that, upon exposure to light, generate reactive oxygen species (ROS) that damage target cells. The aldehyde group can be used to attach photosensitizer moieties or other functional groups that enhance light absorption or cellular uptake. Preliminary studies suggest that certain derivatives of this compound exhibit potent PDT activity against cancer cells while maintaining low toxicity towards healthy tissues.

The synthesis of 5-bromo-2-methyl-indazole-3-carbaldehyde typically involves multi-step organic transformations starting from commercially available precursors such as bromoindole or methyl-substituted indole derivatives. Key steps often include halogenation reactions to introduce the bromine atom at the desired position, followed by formylation or oxidation to install the aldehyde functionality. Advanced synthetic techniques such as palladium-catalyzed cross-coupling reactions can also be employed to introduce additional substituents with high precision.

In conclusion, 5-bromo-2-methyl-indazole-3-carbaldehyde (CAS No. 1251023-52-5) is a versatile intermediate with significant potential in pharmaceutical research. Its unique structural features—comprising an indazole core with bromine and methyl substituents—make it a valuable building block for developing novel therapeutic agents. Ongoing studies continue to explore its applications in kinase inhibition, photodynamic therapy, and other areas where precise molecular modifications are required. As research progresses, this compound is expected to contribute further to advancements in drug discovery and medicinal chemistry.

• 4002-83-9(1-Methyl-1H-indazole-3-carbaldehyde)
• 34252-54-5(2-Methyl-2H-indazole-3-carbaldehyde)
• 845751-62-4(7-Bromo-2,3-dimethyl-2H-indazole)
• 1159511-85-9(4-Bromo-2,3-Dimethyl-2H-Indazole)
• 845751-70-4(7-Bromo-2-methyl-2H-indazole-3-carbaldehyde)
• 201227-38-5(5-Bromo-1H-indazole-3-carbaldehyde)
• 701910-30-7(7-Bromo-2-methyl-2H-indazole-3-carboxylic acid)
• 1142189-49-8(6-Bromo-2,3-dimethyl-2H-indazole)
• 1021859-33-5(6-bromo-2-methyl-2H-indazole-3-carboxylic acid)
• 878064-16-5(5-Bromo-2,3-dimethyl-2H-indazole)